EXOMEGA Face calming eyelid balm -
Tolerability & efficacy study of a supportive care for eyelid prone to atopy subjects treated with topical calcineurin inhibitors
EXOMEGA Face calming eyelid balm -
Tolerability & efficacy study of a supportive care for eyelid prone to atopy subjects treated with topical calcineurin inhibitors
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
18
Years old
Max. Age
50
Years old
Gender
All
Brief summary
The objectives of this study were to assess the benefit and tolerance of this eyelid balm, when applied in association with topical calcineurin inhibitors 0.1%.
The subjects' eyelids were evaluated during 1 dermatological consultation on day 1, after 3 days, 5 days, 1 week and 2 weeks.
Field of application :
Dermatology
Target :
Prone to atopy face
Dermo-cosmetic product :
EXOMEGA Face calming eyelid balm
Brand :
A-DERMA
Start Date :
September 2025
End Date :
February 2026
Number of subjects :
33
Countries :
Poland
Study ID :
VP170-RV5258A